What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
MicroSynbiotiX, an early-stage biotech company based in Ireland, is developing oral vaccines to prevent infectious diseases in farmed fish. We spoke with CEO and co-founder, Simon Porphy, about his transgenic microalgae technology and his startup journey.
We are a synthetic biology company. We genetically modify microalgae to produce vaccines and therapeutic proteins of interest. We are first targeting the aquaculture industry and creating products to treat and prevent deadly viral and bacterial diseases in fish and shrimp. Our long-term goal is to replace antibiotics...